Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vardenafil Preferred Dose Study in Erectile Dysfunction
NCT00661700Phase 3Completed
- Sponsor
- Bayer
- Start
- Apr 2003
- Primary completion
- May 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in erectile dysfunction (ED) comparing Vardenafil with Placebo (2 arms). Primary endpoint: International Index of Erectile Function - Erectile Function Domain at 18 weeks. Started Apr 2003; status: completed.
02
Drugs
vardenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00661700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00661700.